177 related articles for article (PubMed ID: 30339684)
1. Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study.
Yarnoff BO; Hoerger TJ; Shrestha SS; Simpson SK; Burrows NR; Anderson AH; Xie D; Chen HY; Pavkov ME;
PLoS One; 2018; 13(10):e0205530. PubMed ID: 30339684
[TBL] [Abstract][Full Text] [Related]
2. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.
Hoerger TJ; Simpson SA; Yarnoff BO; Pavkov ME; Ríos Burrows N; Saydah SH; Williams DE; Zhuo X
Am J Kidney Dis; 2015 Mar; 65(3):403-11. PubMed ID: 25468386
[TBL] [Abstract][Full Text] [Related]
3. Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults.
Kim YJ; Hwang SD; Oh TJ; Kim KM; Jang HC; Kimm H; Kim HC; Jee SH; Lim S
Metab Syndr Relat Disord; 2017 Oct; 15(8):416-422. PubMed ID: 28832275
[TBL] [Abstract][Full Text] [Related]
4. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of chronic kidney disease in the United States.
Coresh J; Selvin E; Stevens LA; Manzi J; Kusek JW; Eggers P; Van Lente F; Levey AS
JAMA; 2007 Nov; 298(17):2038-47. PubMed ID: 17986697
[TBL] [Abstract][Full Text] [Related]
6. Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.
Inker LA; Tighiouart H; Aspelund T; Gudnason V; Harris T; Indridason OS; Palsson R; Shastri S; Levey AS; Sarnak MJ
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1575-84. PubMed ID: 26286924
[TBL] [Abstract][Full Text] [Related]
7. Risk for chronic kidney disease increases with obesity: Health Survey for England 2010.
MacLaughlin HL; Hall WL; Sanders TA; Macdougall IC
Public Health Nutr; 2015 Dec; 18(18):3349-54. PubMed ID: 25743030
[TBL] [Abstract][Full Text] [Related]
8. Lifetime incidence of CKD stages 3-5 in the United States.
Grams ME; Chow EK; Segev DL; Coresh J
Am J Kidney Dis; 2013 Aug; 62(2):245-52. PubMed ID: 23566637
[TBL] [Abstract][Full Text] [Related]
9. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
[TBL] [Abstract][Full Text] [Related]
10. Obesity, Metabolic Abnormality, and Progression of CKD.
Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
[TBL] [Abstract][Full Text] [Related]
13. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
Rahman M; Xie D; Feldman HI; Go AS; He J; Kusek JW; Lash J; Miller ER; Ojo A; Pan Q; Seliger SL; Steigerwalt S; Townsend RR;
Am J Nephrol; 2014; 40(5):399-407. PubMed ID: 25401485
[TBL] [Abstract][Full Text] [Related]
14. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives.
Satirapoj B; Supasyndh O; Mayteedol N; Punpanich D; Chaiprasert A; Nata N; Ruangkanchanasetr P; Kanjanakul I; Choovichian P
Nephrology (Carlton); 2013 Mar; 18(3):229-34. PubMed ID: 23279639
[TBL] [Abstract][Full Text] [Related]
15. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
16. Fast GFR decline and progression to CKD among primary care patients with preserved GFR.
Koraishy FM; Hooks-Anderson D; Salas J; Rauchman M; Scherrer JF
Int Urol Nephrol; 2018 Mar; 50(3):501-508. PubMed ID: 29404927
[TBL] [Abstract][Full Text] [Related]
17. Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.
Sharma D; Hawkins M; Abramowitz MK
Clin J Am Soc Nephrol; 2014 Dec; 9(12):2079-88. PubMed ID: 25392147
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study.
Kaze FF; Halle MP; Mopa HT; Ashuntantang G; Fouda H; Ngogang J; Kengne AP
BMC Nephrol; 2015 Jul; 16():96. PubMed ID: 26149764
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
[TBL] [Abstract][Full Text] [Related]
20. Obesity and chronic kidney disease: A population-based study among South Koreans.
Evangelista LS; Cho WK; Kim Y
PLoS One; 2018; 13(2):e0193559. PubMed ID: 29489920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
